Literature DB >> 33347928

Protective effects of polysaccharides on cerebral ischemia: A mini-review of the mechanisms.

Huanhuan Meng1, Weifeng Jin1, Li Yu2, Shouchao Xu1, Haitong Wan3, Yu He4.   

Abstract

Cerebral ischemia, a common cerebrovascular disease, is one of the great threats to human health. Nowadays, many drugs used in the treatment of cerebral ischemia such as clot busting drugs, antiplatelet drugs, and neuroprotective drugs have limits. It is urgent finding new effective treatments for the patients. Researches have confirmed that many kinds of polysaccharides from natural resources possess therapeutic effects on cerebral ischemia, but are still lack of a comprehensively understanding. In this paper, based on the pathophysiology of cerebral ischemic injury, we summarize the latest discoveries and advancements of 29 kinds of polysaccharides, focusing on their ameliorating effects on cerebral ischemia and the underlying mechanisms. Several mechanisms are involved, mainly including antioxidant activities, anti-inflammatory activities, regulating neuron apoptosis, as well as resisting nitrosative stress injury. Besides, polysaccharides show protective effects through certain signaling pathways including PI3K/Akt, MAPK, and NF-κB, PARP-1/AIF, JNK3/c-Jun/Fas-L, and Nrf2/HO-1 signaling pathways. The main goal of this mini-review is to emphasize the important roles of polysaccharides in attenuating cerebral ischemic injury through the elucidation of mechanisms.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebral ischemia; Pathophysiology; Polysaccharides; Protective mechanisms

Mesh:

Substances:

Year:  2020        PMID: 33347928     DOI: 10.1016/j.ijbiomac.2020.12.124

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  7 in total

1.  Targeting the Erk1/2 and autophagy signaling easily improved the neurobalst differentiation and cognitive function after young transient forebrain ischemia compared to old gerbils.

Authors:  Fuxing Wang; Zihao Xia; Peng Sheng; Yu Ren; Jiajia Liu; Lidong Ding; Bing Chun Yan
Journal:  Cell Death Discov       Date:  2022-02-26

2.  Histone Methyltransferases SUV39H1 and G9a and DNA Methyltransferase DNMT1 in Penumbra Neurons and Astrocytes after Photothrombotic Stroke.

Authors:  Svetlana Sharifulina; Valentina Dzreyan; Valeria Guzenko; Svetlana Demyanenko
Journal:  Int J Mol Sci       Date:  2021-11-19       Impact factor: 5.923

3.  Protective role of activating transcription factor 3 against neuronal damage in rats with cerebral ischemia.

Authors:  Na Ma; Gaixia Li; Xiuxin Fu
Journal:  Brain Behav       Date:  2022-03-08       Impact factor: 3.405

4.  Study on the Mechanism of Üstikuddus Sherbiti in Ischemic Cerebrovascular Diseases: Based on Network Pharmacology.

Authors:  Aman Gul; Mutalifu Aimaiti; Tuerhong Tuerxun; Raziye Amat; Ayinuer Reheman; Min Fang Zhang; Nassirhadjy Memtily
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-08       Impact factor: 2.650

Review 5.  Current advances and potential trends of the polysaccharides derived from medicinal mushrooms sanghuang.

Authors:  Hao Wang; Jin-Xin Ma; Miao Zhou; Jing Si; Bao-Kai Cui
Journal:  Front Microbiol       Date:  2022-08-03       Impact factor: 6.064

Review 6.  The Role of NLRP3 Inflammasome in Cerebrovascular Diseases Pathology and Possible Therapeutic Targets.

Authors:  Rongrong Bai; Yue Lang; Jie Shao; Yu Deng; Reyisha Refuhati; Li Cui
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

Review 7.  Recent Advances in Chinese Herbal Medicine for Cerebral Ischemic Reperfusion Injury.

Authors:  Ping Huang; Haitong Wan; Chongyu Shao; Chang Li; Ling Zhang; Yu He
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.